Turning Point Therapeutics Stock Jumps 116% on Acquisition by Bristol Myers
(Turning Point) Shares of Turning Point Therapeutics rose more than 116% on Friday after agreeing to be acquired by Bristol Myers Squibb at $76.00 per share. The all-cash deal values…